"Electrophysiologic Studies and Catheter Ablations"

During the past decade, Jorge Diaz, M.D. , P.A. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jorge Diaz, M.D. , P.A." are "Heart Failure" (2 trials), "Bradycardia" (1 trials), "Heart Disease" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Jorge Diaz, M.D. , P.A." in a lesser frequency.

Most popular intervention types in "Jorge Diaz, M.D. , P.A." are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "BiV/MPP" (1 trials), "Cardiac Rhythm Management device" (1 trials), "MPP" (1 trials) and "St. Jude Medical Optisure Lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jorge Diaz, M.D. , P.A." are 4 trials for "All" genders.

Currently, there are NaN active trials in "Jorge Diaz, M.D. , P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Jorge Diaz, M.D. , P.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jorge Diaz, M.D. , P.A., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".